SlideShare a Scribd company logo
Julien Beauté, ECDC
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Evaluation of severe influenza
surveillance in Europe
Background
• 2009 influenza pandemic
− First attempt to monitor severe cases at EU level
− Rapid development of surveillance – July 2009
• 2010-to the present date
− Six to ten EU/EEA countries reporting (seven for the
2013/14 season)
− Thirteen countries reported SARI data to EuroFlu for
the 2013/14 season (including two EU countries)
− Cases admitted to intensive care units or any ward
− Sentinel or comprehensive surveillance
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Outputs
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
• Weekly influenza bulletins
• ECDC seasonal risk assessment
• Annual reports
• Peer-reviewed publications
Evaluation of severe influenza surveillance
• To provide ECDC with:
− Clear statement on epidemiological and public health
usefulness
− Future scenarios and recommendations
• Requested deliverables:
− Description of the surveillance of severe influenza in
all the EU/EEA states
− Review of the surveillance at the EU/EEA level
− Comparison with systems elsewhere
− Guidance for future
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Evaluation of severe influenza surveillance
• Findings:
− Heterogeneity of systems in
place hinders any significant
added value from an European
perspective
− Example of federally organised
countries (e.g. U.S.) strongly
argues in favour of more
harmonised systems
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Key features of severe influenza
surveillance systems in EU/EEA countries
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
37th ECDC Advisory Forum, 27 Feb 2014
• Options
− Abandon severe influenza surveillance
− Proceed with the current strategy aiming at
improving harmonisation and increasing the number
of participating countries
− Proceed with the current system, but restrict severe
influenza surveillance to intensive care units
− Establish a new surveillance system based on a
European network of sentinel hospitals
− …
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Recommendations
• 37th ECDC Advisory Forum, 27 Feb 2014
– Proceed with the current system, but restrict severe
influenza surveillance to intensive care units
– Clarify the objectives of severe influenza surveillance
at the European level
• EISN Coordination Committee meeting, 19 Mar 2014
– Convince countries collecting data to participate
– Agree on denominator data
– Explore alternative monitoring systems
– Estimate risk factors for severe disease
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014

More Related Content

What's hot

Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
jarati
 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confounding
Tarek Tawfik Amin
 
Cost Utility Analysis
Cost Utility AnalysisCost Utility Analysis
Cost Utility Analysis
Prabesh Ghimire
 
Communicable diseases tb
Communicable diseases  tbCommunicable diseases  tb
Communicable diseases tb
drjagannath
 
Cohort Study
Cohort StudyCohort Study
Cohort Study
Achyut Raj Pandey
 
58864328 tb-hiv-research-proposal-harish
58864328 tb-hiv-research-proposal-harish58864328 tb-hiv-research-proposal-harish
58864328 tb-hiv-research-proposal-harish
homeworkping3
 
Observational analytical study: Cross-sectional, Case-control and Cohort stu...
Observational analytical study:  Cross-sectional, Case-control and Cohort stu...Observational analytical study:  Cross-sectional, Case-control and Cohort stu...
Observational analytical study: Cross-sectional, Case-control and Cohort stu...
Prabesh Ghimire
 
Randomized Controlled Trial (RCT)
Randomized Controlled Trial (RCT)Randomized Controlled Trial (RCT)
Randomized Controlled Trial (RCT)
Dr. Animesh Gupta
 
Health technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMERHealth technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMER
Yogesh Arora
 
Observational Research designs: detailed description
Observational Research designs: detailed description Observational Research designs: detailed description
Observational Research designs: detailed description
Tarek Tawfik Amin
 
Precision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Opportunities and Challenges for Clinical TrialsPrecision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Opportunities and Challenges for Clinical Trials
Medpace
 
Cohort study
Cohort studyCohort study
Cohort study
mgmcricommunitymed
 
Surrogate endpoints in clinical trial
Surrogate endpoints in clinical trialSurrogate endpoints in clinical trial
Surrogate endpoints in clinical trial
Amol Patil
 
Designs of clinical trials
Designs of clinical trialsDesigns of clinical trials
Designs of clinical trials
Dr. Prashant Shukla
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overview
shashi sinha
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
DrRenuYadav2
 
Bias in epidemiology uploaded
Bias in epidemiology uploadedBias in epidemiology uploaded
Bias in epidemiology uploaded
Kumar Mrigesh
 
Integrated Diseases Surveillance Project - IDSP India
Integrated Diseases Surveillance Project - IDSP IndiaIntegrated Diseases Surveillance Project - IDSP India
Integrated Diseases Surveillance Project - IDSP IndiaRizwan S A
 
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
Kevin Clauson
 

What's hot (20)

Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confounding
 
Cost Utility Analysis
Cost Utility AnalysisCost Utility Analysis
Cost Utility Analysis
 
Communicable diseases tb
Communicable diseases  tbCommunicable diseases  tb
Communicable diseases tb
 
Cohort Study
Cohort StudyCohort Study
Cohort Study
 
58864328 tb-hiv-research-proposal-harish
58864328 tb-hiv-research-proposal-harish58864328 tb-hiv-research-proposal-harish
58864328 tb-hiv-research-proposal-harish
 
Observational analytical study: Cross-sectional, Case-control and Cohort stu...
Observational analytical study:  Cross-sectional, Case-control and Cohort stu...Observational analytical study:  Cross-sectional, Case-control and Cohort stu...
Observational analytical study: Cross-sectional, Case-control and Cohort stu...
 
Randomized Controlled Trial (RCT)
Randomized Controlled Trial (RCT)Randomized Controlled Trial (RCT)
Randomized Controlled Trial (RCT)
 
Health technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMERHealth technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMER
 
Observational Research designs: detailed description
Observational Research designs: detailed description Observational Research designs: detailed description
Observational Research designs: detailed description
 
Precision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Opportunities and Challenges for Clinical TrialsPrecision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Opportunities and Challenges for Clinical Trials
 
Cohort study
Cohort studyCohort study
Cohort study
 
Surrogate endpoints in clinical trial
Surrogate endpoints in clinical trialSurrogate endpoints in clinical trial
Surrogate endpoints in clinical trial
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Designs of clinical trials
Designs of clinical trialsDesigns of clinical trials
Designs of clinical trials
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overview
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Bias in epidemiology uploaded
Bias in epidemiology uploadedBias in epidemiology uploaded
Bias in epidemiology uploaded
 
Integrated Diseases Surveillance Project - IDSP India
Integrated Diseases Surveillance Project - IDSP IndiaIntegrated Diseases Surveillance Project - IDSP India
Integrated Diseases Surveillance Project - IDSP India
 
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
 

Similar to Evaluation of severe influenza surveillance in europe

Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
European Centre for Disease Prevention and Control
 
Implementation of the International Health Regulations (2005) in the WHO Euro...
Implementation of the International Health Regulations (2005) in the WHO Euro...Implementation of the International Health Regulations (2005) in the WHO Euro...
Implementation of the International Health Regulations (2005) in the WHO Euro...
WHO Regional Office for Europe
 
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
European Centre for Disease Prevention and Control
 
Persistent differences in health outcomes for major medical conditions across...
Persistent differences in health outcomes for major medical conditions across...Persistent differences in health outcomes for major medical conditions across...
Persistent differences in health outcomes for major medical conditions across...
THL
 
Antiviral treatment policy
Antiviral treatment policyAntiviral treatment policy
Options for RSV surveillance in Europe
Options for RSV surveillance in EuropeOptions for RSV surveillance in Europe
Options for RSV surveillance in Europe
European Center for Disease Prevention and Control (ECDC)
 
Pete-Kinross-EPIET-Fellowship-Portfolio
Pete-Kinross-EPIET-Fellowship-PortfolioPete-Kinross-EPIET-Fellowship-Portfolio
Pete-Kinross-EPIET-Fellowship-PortfolioPete Kinross
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
European Centre for Disease Prevention and Control
 
Eu lab cap update
Eu lab cap updateEu lab cap update
ECDC and WHO collaborative activities to improve laboratory preparedness
ECDC and WHO collaborative activities to improve laboratory preparedness ECDC and WHO collaborative activities to improve laboratory preparedness
ECDC and WHO collaborative activities to improve laboratory preparedness
European Center for Disease Prevention and Control (ECDC)
 
WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)
European Centre for Disease Prevention and Control (ECDC)
 
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDCInfluenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
DRIVE research
 
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
WHO Regional Office for Europe
 
Avian influenza workshop 2015_ecdc
Avian influenza workshop 2015_ecdcAvian influenza workshop 2015_ecdc
Avian influenza workshop 2015_ecdc
Cornelia Adlhoch
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
European Centre for Disease Prevention and Control
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
European Centre for Disease Prevention and Control
 
Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)
WHO Regional Office for Europe
 
CBA on reference laboratories human pathogens
CBA on reference laboratories human pathogensCBA on reference laboratories human pathogens
CBA on reference laboratories human pathogens
European Center for Disease Prevention and Control (ECDC)
 
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
European Centre for Disease Prevention and Control (ECDC)
 

Similar to Evaluation of severe influenza surveillance in europe (20)

Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
 
Implementation of the International Health Regulations (2005) in the WHO Euro...
Implementation of the International Health Regulations (2005) in the WHO Euro...Implementation of the International Health Regulations (2005) in the WHO Euro...
Implementation of the International Health Regulations (2005) in the WHO Euro...
 
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
 
Persistent differences in health outcomes for major medical conditions across...
Persistent differences in health outcomes for major medical conditions across...Persistent differences in health outcomes for major medical conditions across...
Persistent differences in health outcomes for major medical conditions across...
 
Antiviral treatment policy
Antiviral treatment policyAntiviral treatment policy
Antiviral treatment policy
 
Options for RSV surveillance in Europe
Options for RSV surveillance in EuropeOptions for RSV surveillance in Europe
Options for RSV surveillance in Europe
 
Pete-Kinross-EPIET-Fellowship-Portfolio
Pete-Kinross-EPIET-Fellowship-PortfolioPete-Kinross-EPIET-Fellowship-Portfolio
Pete-Kinross-EPIET-Fellowship-Portfolio
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
 
Eu lab cap update
Eu lab cap updateEu lab cap update
Eu lab cap update
 
Session 25 andrzej_rys
Session 25 andrzej_rysSession 25 andrzej_rys
Session 25 andrzej_rys
 
ECDC and WHO collaborative activities to improve laboratory preparedness
ECDC and WHO collaborative activities to improve laboratory preparedness ECDC and WHO collaborative activities to improve laboratory preparedness
ECDC and WHO collaborative activities to improve laboratory preparedness
 
WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)
 
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDCInfluenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
 
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
 
Avian influenza workshop 2015_ecdc
Avian influenza workshop 2015_ecdcAvian influenza workshop 2015_ecdc
Avian influenza workshop 2015_ecdc
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
 
Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)
 
CBA on reference laboratories human pathogens
CBA on reference laboratories human pathogensCBA on reference laboratories human pathogens
CBA on reference laboratories human pathogens
 
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
 

More from European Centre for Disease Prevention and Control

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
European Centre for Disease Prevention and Control
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
European Centre for Disease Prevention and Control
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
European Centre for Disease Prevention and Control
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
European Centre for Disease Prevention and Control
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
European Centre for Disease Prevention and Control
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
European Centre for Disease Prevention and Control
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
European Centre for Disease Prevention and Control
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
European Centre for Disease Prevention and Control
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
European Centre for Disease Prevention and Control
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
European Centre for Disease Prevention and Control
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
European Centre for Disease Prevention and Control
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
European Centre for Disease Prevention and Control
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
European Centre for Disease Prevention and Control
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
European Centre for Disease Prevention and Control
 

More from European Centre for Disease Prevention and Control (20)

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 

Recently uploaded

US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complex
Clive Bates
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
Sabbu Khatoon
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
gauripg8
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Catherine Liao
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Catherine Liao
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Catherine Liao
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
hypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptxhypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptx
Dr. Rahul Shah
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
kevinkariuki227
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
Catherine Liao
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
AkashGanganePatil1
 

Recently uploaded (20)

US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complex
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
hypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptxhypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptx
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 

Evaluation of severe influenza surveillance in europe

  • 1. Julien Beauté, ECDC Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014 Evaluation of severe influenza surveillance in Europe
  • 2. Background • 2009 influenza pandemic − First attempt to monitor severe cases at EU level − Rapid development of surveillance – July 2009 • 2010-to the present date − Six to ten EU/EEA countries reporting (seven for the 2013/14 season) − Thirteen countries reported SARI data to EuroFlu for the 2013/14 season (including two EU countries) − Cases admitted to intensive care units or any ward − Sentinel or comprehensive surveillance Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 3. Outputs Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014 • Weekly influenza bulletins • ECDC seasonal risk assessment • Annual reports • Peer-reviewed publications
  • 4. Evaluation of severe influenza surveillance • To provide ECDC with: − Clear statement on epidemiological and public health usefulness − Future scenarios and recommendations • Requested deliverables: − Description of the surveillance of severe influenza in all the EU/EEA states − Review of the surveillance at the EU/EEA level − Comparison with systems elsewhere − Guidance for future Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 5. Evaluation of severe influenza surveillance • Findings: − Heterogeneity of systems in place hinders any significant added value from an European perspective − Example of federally organised countries (e.g. U.S.) strongly argues in favour of more harmonised systems Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 6. Key features of severe influenza surveillance systems in EU/EEA countries Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 7. 37th ECDC Advisory Forum, 27 Feb 2014 • Options − Abandon severe influenza surveillance − Proceed with the current strategy aiming at improving harmonisation and increasing the number of participating countries − Proceed with the current system, but restrict severe influenza surveillance to intensive care units − Establish a new surveillance system based on a European network of sentinel hospitals − … Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 8. Recommendations • 37th ECDC Advisory Forum, 27 Feb 2014 – Proceed with the current system, but restrict severe influenza surveillance to intensive care units – Clarify the objectives of severe influenza surveillance at the European level • EISN Coordination Committee meeting, 19 Mar 2014 – Convince countries collecting data to participate – Agree on denominator data – Explore alternative monitoring systems – Estimate risk factors for severe disease Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014